Moderna Shares Double After Experimental MRNA Cancer Treatment Passes Key Test
WASHINGTON, (UrduPoint / Pakistan Point News / WAM – 20th Aug, 2026) Moderna shares more than doubled Wednesday after it announced initial results from a study of an experimental cancer treatment that would be the first of its kind if approved by regulators. Moderna and Merck are developing a treatment using an mRNA-based cancer vaccine…